Sitagliptin Teva 100 mg filmom obložene tablete
Name | Sitagliptin Teva 100 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-646716317 |
Active Substance | sitagliptinmalat |
Composition | jedna tableta sadrži 100 mg sitagliptina u obliku sitagliptinmalata |
Pharmaceutical Form | filmom obložena tableta |
Manufacturer | Teva Gyogyszergyar Zrt., Debrecen, Mađarska
Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Teva Pharma B.V., Haarlem, Nizozemska Actavis International Ltd., Luqa, Malta Balkanpharma - Dupnitsa AD, Dupnitsa, Bugarska |
Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
Marketing Authorisation Date | 18.06.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/134 |
Registration Number | 381-12-01/154-21-02 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | A10BH01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |